Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Eytan Stein
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Eytan Stein
220 views
May 14, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Hematologic Transplantation and Malignancies
11:20
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Validation of the Composite CR Definitions …

Feat. J. Bewersdorf
11:00
ASH 2022 Conference Coverage

ASH 2022: Management of Accelerated and Blast-Phase MPN

Feat. R. Rampal
23:13
MDS Foundation

MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…

Feat. E. Bernard
11:04
ASH 2021 Conference Coverage on VuMedi

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …

Feat. J. Bewersdorf
17:46
2021 International Congress on Myeloproliferative Neoplasms

Which Published Schemas Are Helpful in MPN Transplant Decisions?

Feat. S. Giralt
14:46
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy

Feat. A. Schoenfeld
10:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: A Tumor-Agnostic TCR-Mimic CAR T-Cell Specific for NDC80 …

Feat. M. Klatt
11:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on CARs for Solid Tumors

Feat. R. O'Cearbhaill
24:52
SOHO Highlights: State of the Art and Next Questions

CAR-T State of the Art: What Therapies Will Be Available in the Next…

Feat. S. Giralt
18:48
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell…

Feat. R. Brentjens
16:23
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…

Feat. R. Rampal
16:42
University of Miami's 2nd Biennial Miami Leukemia Symposium

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of R…

Feat. E. Stein
40:55
Memorial Sloan Kettering Cancer Center

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and …

Feat. M. Perales
23:23
Memorial Sloan Kettering Cancer Center

Complication of AlloHSCT: Phases of Complications, Classification of…

Feat. M. Perales
17:30
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CNS Toxicity of CAR-T in Hematologic Malignancies: Clinical Manifest…

Feat. B. Santomasso
65:45
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Setting Up a CAR T Program Ins and Outs: Institutional Program Devel…

Feat. S. Giralt
23:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…

Feat. B. Santomasso